Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
May 4, 2021
Patent Application Number
16813535
Date Filed
March 9, 2020
Patent Citations
Patent Citations Received
Patent Primary Examiner
Patent abstract
Compositions and methods for treating hyperinsulinemic hypoglycemia, such as hyperinsulinemic hypoglycemia after bariatric surgery, are provided. In some embodiments, an effective amount of the glucagon-like peptide-1 receptor antagonist exendin(9-39) is subcutaneously administered twice per day.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
